Universe Pharmaceuticals Inc
9 hedge funds and large institutions have $168K invested in Universe Pharmaceuticals Inc in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
1,192% more capital invested
Capital invested by funds: $13K → $168K (+$155K)
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
350% more funds holding
Funds holding: 2 → 9 (+7)
18.79% more ownership
Funds ownership: 0.15% → 18.94% (+19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$672K |
| 2 |
MML Investors Services
Springfield,
Massachusetts
|
+$663K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$257K |
| 4 |
Renaissance Technologies
New York
|
+$111K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
+$69.7K |
Top Sellers
UPC Hedge Fund Activity: Q3 2024 in Review
9 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q3 2024, worth a combined $168K — up 1,192% from $13K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new UPC positions and 1 closed out — a net gain of 7 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $672K.
- 9 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q3 2024, up from 2 in Q2 2024.
- Funds reported $168K of Universe Pharmaceuticals Inc stock for Q3 2024, up 1,192% quarter-over-quarter.
- 8 funds opened new Universe Pharmaceuticals Inc positions in Q3 2024 and 1 closed out, a net change of +7 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q3 2024 was UBS Group, an estimated $672K added.
Based on aggregated 13F filings for Q3 2024.